UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000009890
Receipt No. R000011586
Scientific Title Phase II clinical trial of the combination of eribulin and trastuzumab for advanced/recurrent HER2-positive breast cancer
Date of disclosure of the study information 2013/02/01
Last modified on 2018/10/10 12:56:32

No. Disposal Last modified on Item of update
1 Insert 2013/01/28 21:59:56
2 Update 2013/02/13 14:03:57 Public title
Acronym
3 Update 2013/02/13 14:04:49 Developmental phase
4 Update 2013/02/13 14:06:56 Recruitment status
5 Update 2015/07/28 09:41:19 TEL
Email
TEL
Email
6 Update 2015/07/28 09:41:56 Recruitment status
7 Update 2018/10/10 12:56:32 Name of primary sponsor
Organization


Contact us.